Harari M, Shani J, Seidl V, Hristakieva E
DMZ-MOR Rehabilitation Clinic, Ein-Bokek (The Dead Sea), Israel.
Int J Dermatol. 2000 Jan;39(1):59-69. doi: 10.1046/j.1365-4362.2000.00840.x.
About 21% of the patients coming yearly to the DMZ Clinic at the Dead Sea for climatotherapy suffer from atopic dermatitis. This is a common, chronic, and relapsing disease which necessitates drug treatment (topical corticosteroids, antimicrobials, antihistamines, or immunomodulators), phototherapy, or climatotherapy. Objective and methods As the improvement in the condition of patients after 4 weeks of climatotherapy at the Dead Sea is remarkable, we undertook to evaluate the demographic factors that have the strongest impact on this beneficial effect, in adults and children. The major factors studied were: gender, previous medical history, previous stays at the Dead Sea, skin type, skin involvement, age, and duration of treatment. Results A retrospective study of 1718 patients revealed that previous treatments at the Dead Sea and stays longer than 4 weeks caused a clearance greater than 95%, the length of sun exposure was no longer than 5 h daily, and there was no impact of the percentage of skin involvement on the clearance of patients staying more than 4 weeks.
s Climatotherapy of atopic dermatitis at the Dead Sea is a highly effective modality for treating this disease. It is also a highly cost-effective method, as the patients take no medications and experience no side-effects. Successful climatotherapy of atopic dermatitis requires strict medical supervision throughout the whole length of the patient's stay on shore.
每年前往死海的非军事区诊所接受气候疗法的患者中，约21%患有特应性皮炎。这是一种常见的慢性复发性疾病，需要药物治疗（局部用皮质类固醇、抗菌药物、抗组胺药或免疫调节剂）、光疗或气候疗法。目的和方法由于在死海进行4周气候疗法后患者病情改善显著，我们着手评估对成人和儿童这种有益效果影响最大的人口统计学因素。研究的主要因素包括：性别、既往病史、既往在死海停留情况、皮肤类型、皮肤受累情况、年龄和治疗持续时间。结果对1718例患者的回顾性研究显示，既往在死海接受治疗且停留超过4周的患者治愈率超过95%，每日阳光照射时长不超过5小时，且皮肤受累百分比对停留超过4周的患者治愈率没有影响。
死海地区针对特应性皮炎的气候疗法是治疗该疾病的一种非常有效的方式。它也是一种性价比很高的方法，因为患者无需服药且无副作用。成功的特应性皮炎气候疗法需要在患者在岸上停留的整个期间进行严格的医疗监督。
